Melpida: Recombinant Adeno-associated Virus (Serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt)

Clinical trial NCT05518188 · RECRUITING

Trial details

NCT number: NCT05518188
Sponsor: Elpida Therapeutics SPC
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Spasticity, Muscle Microcephaly Intellectual Deficiency Growth Retardation SPG50 Spastic Paraplegia

Start date: 2023-02-15
Primary completion: 2028-10-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.